5Geoffrey O. Entrepreneurship in UK biotechnology: the role of public policy. The Diebold Institute Entrepreneurship and Public Policy Project ,2001,14:6-28.
6Charlotte B. How and when did we get here? an historical institutionalist analysis of EU biotechnology policy. Journal of European Integration, 2011, 34 (4) : 341 - 357.
7Henderson R, Orsenigo L, Pisano G. The Pharmaceutical Industry and the Revolution in Molecular Biology: Exploring the Interactions Between Scientific, Institutional and Organizational Change in The Sources of Industrial Advantages. Cambridge : Cambridge University Press, 1999. 10-18, 24-35, 52-68.
8Calin Gurau, Leo-Paul Dana, el al. Academic entrepreneurship in UK biotechnology firms: alternative models and the associated performance. Journal of Enterprising Communities: People and Places in the Global Economy, 2012,6 (2) : 154-168.
9Cockburn I, Henderson R. Public-private interaction in pharmaceutical research. Proc Natl Acad Sci USA, 1996, 93: 12725-12730.
10Goldman M. Industrial biotechnology in the UK: a funder' s perspective Goldman Merlin. Industrial Biotechnology, 2011, 7 (4) : 269-271.
